Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Jul 6;27(9):1390–1400. doi: 10.1177/0963689718782442

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2018

This article is distributed under the terms of the Creative Commons Attribution 4.0 License (http://www.creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Fig. 1. — Experimental design of this study. We conducted an efficacy test and safety test of ADSC CellSaic. (A) Efficacy test: therapeutic effects of hADSC/cADSC CellSaic, evaluated in DSS-induced mouse model, compared with hADSC/cADSC suspension; Body weight was measured. Seven days after administration, mice were sacrificed, colon length was measured, and histological evaluation was conducted. (B) Safety test: Tumorigenicity and toxicity tests were conducted. cADSC CellSaic evaluated in NOG mouse. Volume of nodules, body weight, and food consumption were measured until 8 weeks. Four and 8 weeks after administration, urinalysis, hematology test, body chemistry test, necropsy organ weight measurement, and histopathological examination were conducted.